Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer:a phase Ⅰ / Ⅱ trial .Results of a randomized phase Ⅲ trial(MPACT)of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastat ......